Showing results (71-80 of 990) with videos related to
Sort By:
Pageof 99
Bayesian Analysis|April 5, 2016
Flexible Bayesian survival modeling with semiparametric time-dependent and shape-restricted covariate effectsThomas A Murray, Brian P Hobbs, Daniel J Sargent, et al.Nature Reviews. Cardiology|May 6, 2015
Genotype-based clinical trials in cardiovascular diseaseNaveen L Pereira, Daniel J Sargent, Michael E Farkouh, et al.Contemporary Clinical Trials|May 28, 2013
A phase II flexible screening design allowing for interim analysis and comparison with historical controlWenting Wu, Brian Bot, Yan Hu, et al.Statistics in Medicine|September 17, 2016
A Bayesian dose-finding design incorporating toxicity data from multiple treatment cyclesJun Yin, Rui Qin, Monia Ezzalfani, et al.Contemporary Clinical Trials|April 29, 2014
Exploring the statistical and clinical impact of two interim analyses on the Phase II design with option for direct assignmentMing-Wen An, Sumithra J Mandrekar, Martin J Edelman, et al.Biostatistics (Oxford, England)|January 22, 2011
Causal assessment of surrogacy in a meta-analysis of colorectal cancer trialsYun Li, Jeremy M G Taylor, Michael R Elliott, et al.Chinese Clinical Oncology|December 9, 2014
Adaptive randomized phase II design for biomarker threshold selection and independent evaluationLindsay A Renfro, Christina M Coughlin, Axel M Grothey, et al.Chinese Clinical Oncology|April 6, 2015
Adaptive randomized phase II design for biomarker threshold selection and independent evaluationLindsay A Renfro, Christina M Coughlin, Axel M Grothey, et al.JAMA Oncology|December 23, 2016
Association of DNA Mismatch Repair and Mutations in BRAF and KRAS With Survival After Recurrence in Stage III Colon Cancers : A Secondary Analysis of 2 Randomized Clinical TrialsFrank A Sinicrope, Qian Shi, Carmen J Allegra, et al.Gastroenterology|October 12, 2014
Molecular markers identify subtypes of stage III colon cancer associated with patient outcomesFrank A Sinicrope, Qian Shi, Thomas C Smyrk, et al.Pageof 99